DEVELOPMENT OF THE NEW BIOCHEMICAL MARKER FOR EARLY DIAGNOSIS OF HEPATIC INFLOW IN SUFFICIENCY
开发用于早期诊断肝血流充足性的新生化标记物
基本信息
- 批准号:04807083
- 负责人:
- 金额:$ 1.22万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1992
- 资助国家:日本
- 起止时间:1992 至 1994
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Hepatic vascular inflow occlusion and complete hepatic vascular exclusion have often been employed in the major liver surgery and liver transplantation. The procedures of hepatic vascular inflow occlusion sometimes cause deterioration of the general circulation, and the reperfusion is occasionally followed by a severe shock state. On the other hand, vascular thrombosis of the grafts is a fatal complication in liver transplantation. In such a case, early detection and immediate retransplantation are essential to rescue the patients.The aim of this study is to find a biochemical indicator for early detection of the surgical complications caused by the hepatic vascular inflow occlusion which is often used in major liver surgery or liver transplantation. Plasma samples obtained from the rats with snaring of portal triad were analyzed by high performance liquid chromatography (HPLC) with electrochemical detection. HPLC analysis indicated that the concentration of an unknown substance in the plasma progressively increased with the occlusion time. After the recirculation it increased further and followed by gradual decrease. The unknown substance purified from the plasma was found to have the same HPLC retention time and absorption spectra as uric acid. The substance was therefore identified to be uric acid. During the occlusion for 30 min, the plasma uric acid values were progressively increased from 0.49<plus-minus>0.04 mg/dl to 2.61<plus-minus>0.06 mg/d which was 5-fold higher than the basal values. In contrast, the concentrations of hepatic enzymes such as asparate aminotransferase and lactate dehydrogenase showed almost no change during the occlusThese results suggest that uric acid could be used as a biochemical marker to assess the influence of hepatic vascular inflow occlusion in early stage of liver surgery and to detect possible occurrence of the vascular complication in liver transplantation.
肝血管流入闭塞和完全的肝血管排斥通常被用于主要的肝脏手术和肝移植中。肝血管流入闭塞的程序有时会导致一般循环的恶化,偶尔再灌注后,紧随其后的是严重的休克状态。另一方面,移植物的血管血栓形成是肝移植的致命并发症。在这种情况下,早期检测和立即再移植对于挽救患者至关重要。本研究的目的是找到生化指标,用于早期检测由肝血管流入闭塞引起的手术并发症,这通常用于主要肝脏手术或肝移植。通过高性能液相色谱(HPLC)分析了从大鼠中获得的血浆样品,并通过电化学检测。 HPLC分析表明,血浆中未知物质的浓度随着闭塞时间逐渐增加。再循环后,它进一步增加,然后逐渐减少。发现从血浆纯化的未知物质具有与尿酸相同的HPLC保留时间和吸收光谱。因此,该物质被确定为尿酸。在闭塞30分钟内,血浆尿酸值从0.49 <plus-minus> 0.04 mg/dL逐渐增加到2.61 <plus-minus> 0.06 mg/d,比基础值高5倍。相反,肝氨基转移酶和乳酸脱氢酶等肝酶的浓度几乎没有变化。
项目成果
期刊论文数量(62)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
小暮公孝: "70%肝切除後、肝再生時におけるBrDU標識率と各生化学マーカーの変動相関について" 日本消化器外科学会雑誌. 27(6). 1674-1674 (1994)
Kimitaka Kogure:“关于70%肝切除后肝脏再生过程中BrDU标记率与各生化标志物变化之间的相关性”日本胃肠外科杂志27(6) 1674-1674(1994)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kimitaka Kogure: "The values of measurement of plasma uric acid in the diagnosis of hepatic inflow occlusion due to vascular thrombosis after liver transplantation" 35th World Congress of International Society of surgery. (Abstract). 342 (1993)
小暮公隆:“血浆尿酸测量在肝移植术后血管血栓形成肝流道闭塞诊断中的价值”,第35届国际外科学会世界大会。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kimitaka Kogure: "The patterns of the changes in plasma uric acid valuesduring hepatectomy." World Journal of Surgery. (Abstract). 13-13 (1994)
Kimitaka Kogure:“肝切除术期间血浆尿酸值的变化模式。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
小暮公孝: "肝再生に対するフォリスタチンの効果" 日本消化器病学会雑誌. 91. 698-698 (1994)
Kimitaka Kogure:“卵泡抑素对肝脏再生的影响”日本胃肠病学会杂志 91. 698-698 (1994)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kimitaka Kogure: "Immunohistochemical study on lymphocyte occurring in heart allograft in rats." Transplantation Proceeding. 24 (5). 1656-1656 (1992)
Kimitaka Kogure:“大鼠同种异体心脏移植物中淋巴细胞的免疫组织化学研究。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KOGURE Kimitaka其他文献
KOGURE Kimitaka的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KOGURE Kimitaka', 18)}}的其他基金
Development of an auxiliary liver using a small intestinal segment packed together with liver microfragments and greater omentum
使用小肠段与肝脏微碎片和大网膜一起开发辅助肝脏
- 批准号:
23659636 - 财政年份:2011
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Elucidation of the liver regeneration mechanism based on the cloning of the liver stem cell and the identification of its localized part in the liver.
基于肝干细胞的克隆及其在肝脏中局部部分的鉴定来阐明肝再生机制。
- 批准号:
17390360 - 财政年份:2005
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Reconstruction of the hepatic tissue exploiting the stem cells of the adult liver.
利用成人肝脏干细胞重建肝组织。
- 批准号:
14370375 - 财政年份:2002
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A DEVELOPMENT OF THE HEPATOCYTE TRANSPLANTATION THERAPY USING THE LIVER STEM-LIKE CELLS DIFFERENCIATED BY CELL BIOTHECNOLOGY
细胞生物技术分化的肝干细胞肝细胞移植治疗的进展
- 批准号:
11557091 - 财政年份:1999
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A DEVELOPMENT OF THE NEW METHOD WHICH ACCELERATES LIVER REGENERATION BY USING ADENOVIRUS EXPRESSION VECTOR SYSTEM
利用腺病毒表达载体系统加速肝脏再生新方法的开发
- 批准号:
09470262 - 财政年份:1997
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A DEVELOPMENT OF THE NEW METHOD WHICH ACCELERATES LIVER REGENERATION BY USING PEPTIDE TECHNOLOGY
开发利用肽技术加速肝脏再生的新方法
- 批准号:
08557076 - 财政年份:1996
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
A DEVELOPMENT OF THE NEW METHOD WHICH ACCELERATES LIVER REGENERATION BY USING FOLLISTATIN,A SPECIFIC BINDING PROTEIN OF ACTIVIN A
激活素A特异性结合蛋白卵泡抑素促进肝脏再生新方法的开发
- 批准号:
07671360 - 财政年份:1995
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
PANX1介导供肝肝窦内皮细胞招募受体CX3CR1+单核巨噬细胞抵抗肝移植术后MRSA感染的机制研究
- 批准号:82370669
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
特异性多肽靶向PANX1调控细胞焦亡维持肝移植脓毒症免疫应答稳态的作用机制
- 批准号:82302427
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
CD147通过Caveolin-1介导内皮细胞损伤参与异种肝移植急性体液性排斥反应的机制研究
- 批准号:82302005
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
上游视角下基于健康系统理论的肝移植受者管理模式构建与实证研究
- 批准号:72374147
- 批准年份:2023
- 资助金额:40.00 万元
- 项目类别:面上项目
Ox-mtDNA通过促进肝巨噬细胞焦亡诱导肝移植缺血再灌注损伤的机制研究
- 批准号:82302010
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Alcohol and calorie-dense diet-mediated hepatic mitochondrial dysregulation
酒精和高热量饮食介导的肝线粒体失调
- 批准号:
10679945 - 财政年份:2023
- 资助金额:
$ 1.22万 - 项目类别:
Development and Testing of an Integrated Care Coordination Intervention for Alcohol Use Disorder Recovery after Liver Transplantation
肝移植后酒精使用障碍康复综合护理协调干预措施的开发和测试
- 批准号:
10723316 - 财政年份:2023
- 资助金额:
$ 1.22万 - 项目类别:
Preoperative immunotherapy in Hepatocellular Carcinoma
肝细胞癌的术前免疫治疗
- 批准号:
10578074 - 财政年份:2023
- 资助金额:
$ 1.22万 - 项目类别:
Ex Vivo Nanoparticle Drug Delivery Targeted to Human Allograft Endothelium
针对人同种异体移植物内皮的体外纳米颗粒药物输送
- 批准号:
10783379 - 财政年份:2023
- 资助金额:
$ 1.22万 - 项目类别:
Investigating the role of frailty on outcomes in acutely ill patients with cirrhosis undergoing liver transplantation in the acute care setting
调查虚弱对在急症护理环境中接受肝移植的急性肝硬化患者的结局的作用
- 批准号:
10658726 - 财政年份:2023
- 资助金额:
$ 1.22万 - 项目类别: